Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T-Cell and NK-Cell Neoplasm”

369 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 369 results

Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Early research (Phase 1)Looking for participantsNCT06660420
What this trial is testing

Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)

Who this might be right for
Phase 1Recurrent MelanomaRefractory Melanoma
M.D. Anderson Cancer Center 39
Large-scale testing (Phase 3)Ended earlyNCT02359162
What this trial is testing

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 50
Testing effectiveness (Phase 2)WithdrawnNCT00387530
What this trial is testing

Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer

Who this might be right for
Gastric CancerHead and Neck CancerLymphoma+1 more
University of California, San Diego
Testing effectiveness (Phase 2)Study completedNCT01431209
What this trial is testing

Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of Nebraska 71
Testing effectiveness (Phase 2)UnknownNCT04405375
What this trial is testing

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Beijing Tongren Hospital 29
Testing effectiveness (Phase 2)Ended earlyNCT00392782
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 24
Not applicableLooking for participantsNCT06067347
What this trial is testing

A Global Study of the PETAL Consortium

Who this might be right for
T-Cell and NK-Cell Neoplasm
Massachusetts General Hospital 1,200
Early research (Phase 1)Study completedNCT00823355
What this trial is testing

Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies

Who this might be right for
Recurrent or Refractory T/NK-cell Malignancies
Mundipharma K.K. 24
Not applicableUnknownNCT03207789
What this trial is testing

T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients

Who this might be right for
T-cell LymphomaNK-Cell LymphomaT-cell Lymphoma Adults
Grupo de Estudos Multicentricos em Onco-Hematologia 500
Very early researchLooking for participantsNCT06643221
What this trial is testing

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

Who this might be right for
LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more
University of Arizona 200
Testing effectiveness (Phase 2)UnknownNCT01178658
What this trial is testing

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Seoul National University Hospital 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Not applicableStudy completedNCT00003196
What this trial is testing

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more
Fred Hutchinson Cancer Center 63
Large-scale testing (Phase 3)UnknownNCT00725231
What this trial is testing

Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP

Who this might be right for
Peripheral T Cell Lymphoma, UnspecifiedAngioimmunoblastic LymphadenopathyExtranodal NK/T-cell Lymphoma
University of Göttingen 274
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07457177
What this trial is testing

Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL

Who this might be right for
NK T-Cell Lymphoma
LIANG WANG 40
Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Testing effectiveness (Phase 2)Ended earlyNCT02808091
What this trial is testing

Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma

Who this might be right for
Extranodal NK-T-CELL LYMPHOMA
National Cancer Centre, Singapore 7
Testing effectiveness (Phase 2)Study completedNCT00365768
What this trial is testing

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Columbia University 56
Testing effectiveness (Phase 2)UnknownNCT03598959
What this trial is testing

Tofacitinib Combined With Chidamide in R/R ENKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Sichuan University 20
Next Page